Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations

Bollettino Chimico Farmaceutico

Volumn 142, Issue 3, 2003, Pages 119-124

  Verma, M Mohan ^a   Kumar, M Thilek ^a   Balasubramaniam, J ^a   Pandit, J K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bioavailability; Dissolution; Nicotinamide; Piroxicam; Solid dispersions; Ulcerogenic Activity

Indexed keywords

DRUG CARRIER; MICROCRYSTALLINE CELLULOSE; NICOTINAMIDE; NICOTINAMIDE PLUS PIROXICAM; PH 102; PIROXICAM; STARCH GLYCOLATE SODIUM; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSIBLE TABLET; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MIXTURE; DRUG SOLUBILITY; HARDNESS; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PHYSICAL CHEMISTRY; RAT; SOLID STATE; STOMACH MUCOSA; THICKNESS; TIME SERIES ANALYSIS; ULCEROGENESIS; X RAY DIFFRACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CAPSULES; HUMANS; NIACINAMIDE; PIROXICAM; RATS; SOLUBILITY; STOMACH ULCER; TABLETS; X-RAY DIFFRACTION;

EID: 0038623650     PISSN: 00066648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Herzfeldt, C.D. Kummel, R., Drug Dev. Ind. Pharm. 1983, 9, 767.
2. Garg, S.K. et al. Indian Drugs 1992, 29, 691.
3. Dhaneria, S.P. et al. Drug Invest. 1993, 6, 300.
4. Barone, J.A. et al. Drug Intell. Clin. Pharm. 1988, 22, 35.
5. Chiou, W.L. Riegelman, S., J. Pharm. Sci. 1971, 60, 1281.
6. Ford, J.L. Pharm. Acta. Helv. 1986, 61, 69.
7. Jachowicz, R. Numberg, E., Int. J. Pharm. 1997, 159, 149.
8. Okonogi, S. et al. Int. J. Pharm. 1997, 156, 175.
9. Portero, A. et al. Int. J. Pharm. 1998, 175, 75.
10. Rasool, A.A. et al. J. Pharm. Sci. 1991, 80, 387.
11. Truelove J. et al. Int. J. Pharm. 1984, 19, 17.
12. Bogdanova, Sv. et al. Int. J. Pharm. 1998, 163, 1.
13. Eshra, A. et al. Pharm. Ind., 1986, 48, 1557.
14. Hamza, Y. et al. Pharm. Ind., 1994, 56, 286.
15. Verma, M. M. et al. Boll. Chim. Farm. 2002, 141, 176.
16. Bhattacharya, M. et al. Drug Dev. Ind. Pharm. 1993, 19, 739.
17. Fernandez, M. et al. Int. J. Pharm. 1993, 98, 29.
18. Fernandez, M. et al. Int. J. Pharm. 1992, 84, 197.
19. Tantishaiyakul, V. et al. Int. J. Pharm. 1996, 143, 59.
20. Khan, K.A.J. Pharm. Pharmacol. 1975, 27, 48.
21. Higuchi, T. Connors, K.A. Phase solubility techniques. In: Reilley. C.N. (Ed.). Advance in Analytical Chemistry and Instrumentation. Willey-Interscience, New York, Vol. 4, pp. 117 (1965).
22. Mummaneni, V. Vasada, R.C. Int. J. Pharm. 1990, 66, 71.
23. Sjokvist, E. Nystrom, C. Int. J. Pharm. 1991, 67, 139.
24. Hobbs, D.C. Twomey, T.M. J. Clin. Pharmacol. 1979, 19, 270.
25. Liversidge, G.G. Conzentino, P. Int. J. Pharm. 1995, 125, 309.
26. Leuner, C. Dressman, J. Eur. J. Pharm. Sci. 2000, 50, 47.
27. Craig, D. Q. M. Int. J. Pharm. 2002, 231, 131.
28. Corrigan, O. I. Drug Dev. Ind. Pharm. 1985, 11, 697.
29. Corrigan, O. I. Drug Dev. Ind. Pharm. 1986, 12, 1777.
30. Dubois, J. L. Ford, J. L. J. Pharm. Pharmacol. 1985, 37, 494.
31. Craig, D. Q. M. Newton, J. M. Int J. Pharm. 1992, 78, 175.
32. Shiraishi, S. et al. J. Pharm. Pharmacol. 1991, 43, 615